Simon Bjerregaard
6Patents
4h-index
7Co-inventors
46Inventor score
Filing activity: Dec 16, 2011 → Feb 19, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9278123B2 | Solid compositions comprising a GLP-1 agonist and a salt of N-(8-(2-hydroxybenzoyl)amino)caprylic acid | Human Necessities | 27 | Active |
| US10086047B2 | Solid compositions comprising a GLP-1 agonist and a salt of N-(8-(2-hydroxybenzoyl)amino)caprylic acid | Human Necessities | 19 | Active |
| US10960052B2 | Solid compositions comprising a GLP-1 agonist and a salt of N-(8-(2-hydroxybenzoyl) amino) caprylic acid | Human Necessities | 10 | Active |
| US11382957B2 | Solid compositions comprising a GLP-1 agonist and a salt of N-(8-(2-hydroxybenzoyl)amino)caprylic acid | Human Necessities | 6 | Active |
| US11167014B2 | Solid glp-1 derivative compositions for oral administration | Human Necessities | 3 | Active |
| US11622996B2 | Solid compositions comprising a GLP-1 agonist and a salt of N-(8-(2-hydroxybenzoyl)amino)caprylic acid | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.